EULAV Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,272
Closed -$712K 300
2018
Q2
$712K Hold
4,272
0.03% 255
2018
Q1
$719K Hold
4,272
0.03% 248
2017
Q4
$699K Sell
4,272
-20,000
-82% -$3.59M 0.03% 254
2017
Q3
$4.97M Buy
24,272
+7,000
+41% +$1.63M 0.24% 138
2017
Q2
$4.2M Sell
17,272
-6,208
-26% -$1.46M 0.21% 150
2017
Q1
$5.61M Sell
23,480
-10,500
-31% -$2.45M 0.29% 118
2016
Q4
$7.14M Sell
33,980
-18,000
-35% -$3.73M 0.38% 87
2016
Q3
$12M Sell
51,980
-15,034
-22% -$3.67M 0.63% 52
2016
Q2
$15.5M Buy
67,014
+11,000
+20% +$2.54M 0.85% 36
2016
Q1
$15M Sell
56,014
-22,531
-29% -$6.45M 0.84% 32
2015
Q4
$24.5M Buy
78,545
+28,800
+58% +$8.57M 1.34% 3
2015
Q3
$13.5M Sell
49,745
-2,000
-4% -$614K 0.77% 36
2015
Q2
$15.7M Hold
51,745
0.82% 23
2015
Q1
$15.4M Buy
51,745
+17,045
+49% +$4.86M 0.79% 23
2014
Q4
$8.93M Hold
34,700
0.48% 79
2014
Q3
$8.37M Buy
34,700
+1,000
+3% +$224K 0.46% 83
2014
Q2
$7.52M Hold
33,700
0.4% 94
2014
Q1
$6.94M Hold
33,700
0.38% 94
2013
Q4
$5.66M Buy
+33,700
New +$5.27M 0.31% 110
2013
Q3
Sell
-37,000
Closed -$4.67M 431
2013
Q2
$4.67M Buy
+37,000
New +$4.19M 0.28% 124

Other funds holding AGN

EULAV Asset Management's AGN Position: Q3 2018 in Review

EULAV Asset Management sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 4,272 shares — an estimated $712K sold.

EULAV Asset Management first reported a position in AGN in Q2 2013 and held it in 20 quarters. The position peaked at $24.5M in Q4 2015. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • EULAV Asset Management reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • EULAV Asset Management sold 4,272 Allergan plc shares in Q3 2018, an estimated $712K.
  • EULAV Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 20 quarters.
  • EULAV Asset Management's Allergan plc position peaked at $24.5M in Q4 2015.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on EULAV Asset Management's 13F filing for Q3 2018, filed 26 Oct 2018.